These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1840326)

  • 41. Abnormal desolvation behavior on solvate of etodolac sodium salt.
    Zawadzki J; Lee HK; DeNeale R; Enever R
    J Pharm Sci; 1991 Jun; 80(6):559-63. PubMed ID: 1834825
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Global safety of etodolac: reports from worldwide postmarketing surveillance studies.
    Serni U
    Rheumatol Int; 1990; 10 Suppl():23-7. PubMed ID: 2150568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetic and pharmacodynamic action of etodolac in patients after oral surgery.
    Boni J; Korth-Bradley J; McGoldrick K; Appel A; Cooper S
    J Clin Pharmacol; 1999 Jul; 39(7):729-37. PubMed ID: 10392328
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enantioselective pharmacokinetics of etodolac in the rat: tissue distribution, tissue binding, and in vitro metabolism.
    Brocks DR; Jamali F
    J Pharm Sci; 1991 Nov; 80(11):1058-61. PubMed ID: 1839997
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Acute hepatitis associated with etodolac therapy].
    Latrive JP; Combaux D; Crépin P; Barbare JC
    Therapie; 1992; 47(1):82-3. PubMed ID: 1387992
    [No Abstract]   [Full Text] [Related]  

  • 46. Etodolac kinetics in the elderly.
    Scatina J; Hicks D; Kraml M; Weidler D; Garg D; Sanda M
    Clin Pharmacol Ther; 1986 May; 39(5):550-3. PubMed ID: 2938866
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Etodolac overdose.
    Boldy DA; Hale KA; Vale JA
    Hum Toxicol; 1988 Mar; 7(2):203-4. PubMed ID: 2967796
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmacokinetics and drug input characteristics for a diclofenac-codeine phosphate combination following oral and rectal administration.
    Hanses A; Spahn-Langguth H; Meiss F; Mutschler E
    Arzneimittelforschung; 1996 Jan; 46(1):57-63. PubMed ID: 8821519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative pharmacokinetic evaluation of compressed suppositories of diclofenac sodium in humans.
    Ramakrishna S; Fadnavis NW; Diwan PV
    Arzneimittelforschung; 1996 Feb; 46(2):175-7. PubMed ID: 8720309
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of the effectiveness and safety of etodolac in prolonged treatment of active osteoarthritis.
    Puccetti L; Ciompi ML
    Int J Clin Pharmacol Res; 1991; 11(3):143-58. PubMed ID: 1839736
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Profile of etodolac: pharmacokinetic evaluation in special populations.
    Brater DC; Lasseter KC
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():25-35. PubMed ID: 2525981
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetic study of etodolac after rectal administration; "in vitro" release kinetics.
    Cadorniga R; Herrero R; Barcia E; Molina IT; Guitierrez JA; Fabregas JL; Martinez-Tobed A
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():389-96. PubMed ID: 1840326
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.